Mucosal biofilms: Challenges and future directions

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 2, 2008, Pages 141-144

  Dongari Bagtzoglou, Anna ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; DERMATITIS; EDITORIAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MICROBIAL COMMUNITY; MUCOSA; MUCOSA BIOFILM; NONHUMAN; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TISSUE INJURY; BACTERIAL INFECTION; BIOFILM; CANDIDA; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; MICROBIOLOGY; MYCOSIS; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

BACTERIAL INFECTIONS; BIOFILMS; CANDIDA; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MYCOSES; RESPIRATORY MUCOSA; STAPHYLOCOCCUS AUREUS;

EID: 45549109081     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.2.141     Document Type: Editorial

References (30)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: acommon cause of persistent infections. Science 284(21), 1318-1322 (1999).
2. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr.Opin. Otolaryngol. Head Neck Surg. 12(3), 185-190 (2004).
3. Madarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J. Appl. Microbiol. 102(5), 1187-1196 (2007).
4. Ehrlich GD, Veeh R, Wang X et al. Mucosal biofilm formation on middle ear mucosa in the Chinchilla model of otitis media. JAMA 287(13), 1710-1715 (2007).
5. Hall-Stoodley L,Hu FZ, Gieseke A et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296(2), 202-211 (2006).
6. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 358(9276), 135-138 (2001).
7. Post JC, Hiller NL, Nistico L, Stoodley P, Ehrlich GD. The role of biofilms in otolaryngologic infections: update 2007. Curr. Opin. Otolaryngol. Head Neck Surg. 15(5), 347-351 (2007).
8. Akiyama H, Morizane S, Yamasaki O, Oono T, Iwatsuki K. Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J. Dermatol. Sci. 32(3), 193-199 (2003).
9. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301(5629), 105-107 (2003).
10. Jansen AM, Lockatell V, Johnson DE, Mobley HL. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect. Immun. 72(12), 7294-7305 (2004).
11. Oggioni MR, Trappetti C, Kadioglu A et al. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol. Microbiol. 61(5), 1196-1210 (2006).
12. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 9(4), 340-345 (2006).
13. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15(2), 194-222 (2002).
14. Cho KH, Caparon MG. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol. Microbiol. 57(6), 1545-1556 (2005).
15. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin. Infect. Dis. 38(12), 1690-1699 (2004).
16. Swidinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 43(7), 3380-3389 (2005).
17. Coticchia J, Zuliani G, Coleman C et al. Biofilm surface area in the pediatric nasopharynx: chronic rhinosinusitis vs obstructive sleep apnea. Arch. Otolaryngol. Head Neck Surg. 133(2), 110-114 (2007).
18. McLaughlin RA, Hoogewerf AJ. Interleukin- 1β-induced growth enhancement of Staphylocaccus aureus occurs in biofilm but not planktonic cultures. Microb. Pathol. 41(2-3), 67-79 (2006).
19. Hong W. Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect. Immun. 75(2), 958-965 (2007).
20. Scaramuzzino DA, McNiff JM, Bessen DE. Humanized in vivo model for streptococcal impetigo. Infect. Immun. 68(5), 2880-2887 (2000).
21. Jesaitis AJ, Franklin M, Berglund D et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J. Immunol. 171(8), 4329-4339 (2003).
22. Walker TS, Tomlin KL, Worthen GS et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 73(6), 3693-3701 (2005).
23. Strathmann M, Wingender J, Flemming HC. Application of fluorescently labelled lectins for the visualization and biochemical characterization of polysaccharides; in biofilms of Pseudomonas aeruginosa. J. Microbiol. Methods 50(3), 237-248 (2002).
24. Leriche V, Sibille P, Carpentier B. Use of an enzyme-linked lectinsorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl. Environ. Microbiol. 66(5), 1851-1856 (2000).
25. Martinez LR, Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect. Immun. 73(10), 6350-6362 (2005).
26. Al-Fartani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55(8), 999-1008 (2006).
27. Lucatorto FM, Franker C, Hardy WD, Chaky S. Treatment of refractory oral candidiasis with fluconazole. A case report. Oral Surg. Oral Med. Oral Pathol. 71(1), 42-44 (1991).
28. Redding SW, Kirkpatrick WR, Coco BJ et al. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J. Clin. Mirrobiol. 40(5), 1879-1881 (2002).
29. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50(11), 3839-3846 (2006).
30. Akiyama H,Oono T, Huh WK et al. Actions of gluco-oligosaccharide against Staphyloccus aureus. J. Dermatol. 29(9), 580-586 (2002).